SCHEMBL8091318

SCHEMBL8091318

CC(C)S(=O)(=O)NC(=O)Nc1ccc(F)cc1.[NaH]

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.56
CA12 O43570 4/20 0.51
CA1 P00915 4/20 0.51
CA2 P00918 4/20 0.51
CA9 Q16790 4/20 0.51
CA4 P22748 1/20 0.51
CA7 P43166 1/20 0.51
PTGS2 P35354 1/20 0.49
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
NPC1 O15118 3/20 0.49
RAB9A P51151 3/20 0.49
MAPT P10636 2/20 0.49
MAPK1 P28482 2/20 0.49
HTT P42858 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
XBP1 P17861 1/20 0.49
GAA P10253 1/20 0.48
TAAR1 Q96RJ0 1/20 0.47
FAAH O00519 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8083304 0.84 ALDH1A1 (0.54) CA12CA1CA2CA9PTGS2
SCHEMBL8095025 0.84 FPR2 (0.55) CA12CA1CA2CA9MEN1
SCHEMBL8083369 0.83 MEN1 (0.59) CA2MEN1KMT2ANPC1RAB9A
SCHEMBL8094980 0.83 TP53 (0.52) TP53CA12CA1CA2CA9
SCHEMBL8091346 0.82 ALDH1A1 (0.56) CA12CA1CA2CA9PTGS2
SCHEMBL8083324 0.82 FPR2 (0.56) CA12CA1CA2CA9MEN1
SCHEMBL8663690 0.81 ACP1 (0.62) TP53CA12CA1CA2CA9
SCHEMBL6463101 0.81 SAE1 (0.51) CA12CA1CA2CA9MEN1
SCHEMBL8097749 0.80 LMNA (0.60) CA2MEN1KMT2ANPC1RAB9A
SCHEMBL9341223 0.79 NPC1 (0.48) TP53CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6147115-A SULFONYLUREIDO-4-HALOBENZENE DERIVATIVES; ANTICARCINOGENIC AGENTS ELI LILLY AND COMPANY (US) 2000-11-14 US disclosed
EP-0467621-B1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them LILLY CO ELI (US) 1994-06-15 EP disclosed
US-5216026-A Administering to the mammal N-1-butanesulfonamide derivatives and salts ELI LILLY AND COMPANY (US) 1993-06-01 US disclosed
EP-0467621-A1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them ELI LILLY AND COMPANY (US) 1992-01-22 EP disclosed